Literature DB >> 28815954

Diaphanospondylodysostosis and ischiospinal dysostosis, evidence for one disorder with variable expression in a patient who has survived to age 9 years.

Janet M Legare1, Kristin Seaborg2,3, Jennifer Laffin4, Philip F Giampietro5.   

Abstract

Diaphanospondylodysostosis (DSD) and ischiospinal dysostosis (ISD) are both rare skeletal dysplasias consisting of abnormal axial skeletal development but normal appendicular skeletal development. Both disorders recently have been found to result from mutations in the BMPER gene. We report a patient with one deletion and one mutation of the BMPER gene who has features most consistent with DSD but who has survived to age 9 years. Survival suggests that DSD and ISD reflect a spectrum of severity of one disease process.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  BMPER; DSD; ISD; diaphanospondylodysostosis; ischiospinal dysostosis; ischiovertebral

Mesh:

Substances:

Year:  2017        PMID: 28815954     DOI: 10.1002/ajmg.a.38395

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Targeted Sequencing of Candidate Regions Associated with Sagittal and Metopic Nonsyndromic Craniosynostosis.

Authors:  Cristina M Justice; Anthony M Musolf; Araceli Cuellar; Wanda Lattanzi; Emil Simeonov; Radka Kaneva; Justin Paschall; Michael Cunningham; Andrew O M Wilkie; Alexander F Wilson; Paul A Romitti; Simeon A Boyadjiev
Journal:  Genes (Basel)       Date:  2022-05-03       Impact factor: 4.141

2.  Successfully Managed Respiratory Insufficiency in a Patient with a Novel Pathogenic Variant of the BMPER Gene: A Case Report.

Authors:  Ho Eun Park; Jin A Yoon; Yong Beom Shin
Journal:  Diagnostics (Basel)       Date:  2022-03-03

3.  Expansion of the mutational spectrum of BMPER leading to diaphanospondylodysostosis and description of the associated disease process.

Authors:  Frederik Braun; Andrea Gangfuß; Petra Stöbe; Tobias B Haack; Bernd Schweiger; Andreas Roos; Ulrike Schara
Journal:  Mol Genet Genomic Med       Date:  2021-07-20       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.